TNF and Sepsis: The study of Wei Zhou suggest XBJI may modulating the IL-17, TNF, NF-κB, and TLR pathways, and targeting IL-1β, IL-6, and TNF, thereby exert therapeutic effects on sepsis (Zhou et al., 2024).